排序方式： 共有57条查询结果，搜索用时 15 毫秒
31.
32.
Oertel Ad. Naef A. Berliner Bethe Therapie Oppenheimer Koenigsfeld Herzfeld Peiper Flaskamp Holfelder Cramer Halberstaedter Grassheim Eisner-Behrend Versé Magnus-Alsleben Vaternahm Christeller Schall A. W. Fischer K. Hirschfeld Eckstein Fischer Griesbach Warsow H. Hirschfeld Nonnenbruch Weigert Bernhardt Erich Meyer Rosenberg W. Israel Dietrich Schrader Jonas Erich Langkr Erich Langer Finkenrath Sachs Sperling Heyn Gerbis 《Journal of molecular medicine (Berlin, Germany)》1925,4(44):2121-2132
Ohne Zusammenfassung 相似文献
33.
H. Kämmerer Flury v. Muralt Gerbis Ulrici Gaupp Kohlrausch 《Journal of molecular medicine (Berlin, Germany)》1939,18(23):824-826
Ohne Zusammenfassung 相似文献
34.
Werner Gottstein Dresel Zangger Gerbis 《Journal of molecular medicine (Berlin, Germany)》1931,10(40):1880-1880
Ohne Zusammenfassung 相似文献
35.
36.
Günther Just H. Braun Jaffé Lewy Herzfeld Weigert Seligmann Versé Eppinger Grassheim Magnus-Alsleben Ulrici Zinn Gerbis D. Ackermann A. W. Fischer v. Lichtenberg W. Israel Klingmüller Finkenrath Melchior Axhausen Valentin Meyer Hirschfeld Mendel Friedemann O. Wiener R. Gaupp Karl Birnbaum H. Hoffmann 《Journal of molecular medicine (Berlin, Germany)》1929,8(5):224-231
Ohne Zusammenfassung 相似文献
37.
Isabella Uzaraga Bev Gerbis Eleanor Holwerda Dan Gillis Elaine Wai 《Supportive care in cancer》2012,20(7):1515-1524
Purpose
The purpose of this study is to assess the effect of topical amitriptyline, ketamine, and lidocaine (AKL) on alleviation of neuropathic pain from radiation dermatitis and the feasibility of a randomized trial.Materials and methods
Eligible subjects had radiation dermatitis with dry or moist desquamation with neuropathic pain and were intolerant or allergic to standard intervention. AKL was applied to painful sites three times a day daily until 2?weeks post-radiotherapy. Subjects were monitored every 2–5?days during radiotherapy and at 2 and 6?weeks after completion of radiotherapy. The University of Washington Neuropathic Pain Scale was used to grade the neuropathic pain before and after use of the interventional gel. Compliance was assessed by asking subjects at each visit how frequently they were using the interventional gel.Results
Over a 14-month period, 16 subjects met eligibility criteria. Eighty-two percent of subjects used the AKL as directed. Five subjects (32%) reported fatigue, and three subjects (19%) reported site irritation from the interventional gel. AKL was shown to significantly reduce (p?<?0.05) pain intensity, sharpness, burning, sensitivity, itchiness, unpleasantness, deepness, and surfaceness levels on a short-term basis (i.e., between pre-treatment and 30?min post-treatment). AKL was shown to significantly reduce (p?<?0.05) burning levels on a long-term basis (i.e., between pre-treatment and 2?weeks post-treatment).Conclusions
AKL was a safe intervention to use with minimal toxicity and good compliance. It significantly reduced several measures of neuropathic pain associated with radiation dermatitis. A larger-scale study would require recruitment from multiple centers. 相似文献38.
Ulrici Kleinschmidt C. Kaufmann Mader Gerbis 《Journal of molecular medicine (Berlin, Germany)》1937,16(33):1159-1160
Ohne Zusammenfassung 相似文献
39.
40.
Paul Martini R. Havemann Hinsberg Schubert Lendle Eppinger Boehm O. Roth B. Lange Zinn Heupke Gerbis Mader Oberniedermyer Klose 《Journal of molecular medicine (Berlin, Germany)》1938,17(8):279-281
Ohne Zusammenfassung 相似文献